Home > R&D Lunch and Learn Series 2022
R&D Lunch and Learn Webinar Recap – October 18
A Deprescribing Approach to Older Adults with Polypharmacy: Addressing Anticholinergic Drug Risk
Medications with anticholinergic properties lead to higher health risk in older adults, especially those taking multiple medications. In this webinar, TRHC’s Clinical Research Scientist Sweilem B. Al Rihani, PharmD, PhD, and Research Pharmacist David Bankes, PharmD, BCGP, discuss the different deprescribing approaches for strong anticholinergic drugs, specifically urinary antimuscarinics (UAMs), in this population.